Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Operating expenses:
Research and development	$ 96,829	$ 48,209
General and administrative	30,043	21,361
Total operating expenses	126,872	69,570
Loss from operations	(126,872)	(69,570)
Other income (expense):
Interest expense	0	(1)
Interest income	3,464	4,041
Other expense	(2,188)	(1,724)
Total other income (expense), net	1,276	2,316
Net loss	$ (125,596)	$ (67,254)
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (3.47)	$ (2.05)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (3.47)	$ (2.05)
Weighted average common shares outstanding, basic (in shares)	36,189,002	32,907,100
Weighted average common share outstanding, diluted (in shares)	36,189,002	32,907,100
Comprehensive loss:
Net loss	$ (125,596)	$ (67,254)
Other comprehensive (loss) income:
Change in unrealized (loss) gain on investments, net	(1,028)	614
Comprehensive loss	$ (126,624)	$ (66,640)